Literature DB >> 24820951

Thalamic metabolic alterations with cognitive dysfunction in idiopathic trigeminal neuralgia: a multivoxel spectroscopy study.

Yuan Wang1, Dan Li, Faxiu Bao, Shaohui Ma, Chenguang Guo, Chenwang Jin, Ming Zhang.   

Abstract

INTRODUCTION: Although abnormalities in metabolite compositions in the thalamus are well described in patients with idiopathic trigeminal neuralgia (ITN), differences in distinct thalamic subregions have not been measured with proton magnetic resonance spectroscopy ((1)H-MRS), and whether there are correlations between thalamic metabolites and cognitive function still remain unknown.
METHODS: Multivoxel MRS was recorded to investigate the metabolic alterations in the thalamic subregions of patients with ITN. The regions of interest were localized in the anterior thalamus (A-Th), intralaminar portion of the thalamus (IL-Th), posterior lateral thalamus (PL-Th), posterior medial thalamus (PM-Th), and medial and lateral pulvinar of the thalamus (PuM-Th and PuL-Th). The N-acetylaspartate to creatine (NAA/Cr) and choline to creatine (Cho/Cr) ratios were measured in the ITN and control groups. Scores of the visual analogue scale (VAS) and the Montreal Cognitive Assessment (MoCA) were analyzed to correlate with the neuroradiological findings.
RESULTS: The NAA/Cr ratio in the affected side of PM-Th and PL-Th in ITN patients was statistically lower than that in the corresponding regions of the thalamus in controls. The NAA/Cr ratio in the affected PM-Th was negatively associated with VAS and disease duration. Furthermore, decreases of NAA/Cr and Cho/Cr were detected in the affected side of IL-Th, and lower Cho/Cr was positively correlated with MoCA values in the ITN group.
CONCLUSIONS: Our result of low level of NAA/Cr in the affected PM-Th probably serves as a marker of the pain-rating index, and decreased Cho/Cr in IL-Th may be an indicator of cognitive disorder in patients with ITN.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24820951     DOI: 10.1007/s00234-014-1376-5

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  44 in total

1.  Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.

Authors:  F A Hanefeld; K Brockmann; P J W Pouwels; B Wilken; J Frahm; P Dechent
Journal:  Neurology       Date:  2005-09-13       Impact factor: 9.910

2.  Chronic pain in adults with an intellectual disability: prevalence, impact, and health service use based on caregiver report.

Authors:  Maria Walsh; Todd G Morrison; Brian E McGuire
Journal:  Pain       Date:  2011-04-17       Impact factor: 6.961

3.  Multiarchitectonic and stereotactic atlas of the human thalamus.

Authors:  A Morel; M Magnin; D Jeanmonod
Journal:  J Comp Neurol       Date:  1997-11-03       Impact factor: 3.215

Review 4.  What to learn from in vivo opioidergic brain imaging?

Authors:  Till Sprenger; Achim Berthele; Stefan Platzer; Henning Boecker; Thomas Rudolf Tölle
Journal:  Eur J Pain       Date:  2005-04       Impact factor: 3.931

5.  Hippocampal metabolic dysfunction in juvenile myoclonic epilepsy: 3D multivoxel spectroscopy study.

Authors:  Aleksandar J Ristić; Jelena Ostojić; Duško Kozić; Nikola M Vojvodić; Ljubica M Popović; Slavko Janković; Vladimir Baščarević; Dragoslav V Sokić
Journal:  J Neurol Sci       Date:  2011-03-21       Impact factor: 3.181

6.  Gray matter volume reduction reflects chronic pain in trigeminal neuralgia.

Authors:  Mark Obermann; Rea Rodriguez-Raecke; Steffen Naegel; Dagny Holle; Daniel Mueller; Min-Suk Yoon; Nina Theysohn; Sebastian Blex; Hans-Christoph Diener; Zaza Katsarava
Journal:  Neuroimage       Date:  2013-02-26       Impact factor: 6.556

Review 7.  Choline-containing phospholipids: relevance to brain functional pathways.

Authors:  Seyed Khosrow Tayebati; Francesco Amenta
Journal:  Clin Chem Lab Med       Date:  2013-03-01       Impact factor: 3.694

8.  Mapping changes of in vivo connectivity patterns in the human mediodorsal thalamus: correlations with higher cognitive and executive functions.

Authors:  András Jakab; Rémi Blanc; Ervin L Berényi
Journal:  Brain Imaging Behav       Date:  2012-09       Impact factor: 3.978

9.  A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson's disease in China.

Authors:  Kun Nie; Yuhu Zhang; Limin Wang; Jiehao Zhao; Zhiheng Huang; Rong Gan; Shaohua Li; Lijuan Wang
Journal:  J Clin Neurosci       Date:  2012-09-06       Impact factor: 1.961

10.  Ensemble encoding of nociceptive stimulus intensity in the rat medial and lateral pain systems.

Authors:  Yang Zhang; Ning Wang; Jin-Yan Wang; Jing-Yu Chang; Donald J Woodward; Fei Luo
Journal:  Mol Pain       Date:  2011-08-24       Impact factor: 3.395

View more
  10 in total

Review 1.  Metabolic Imaging in Humans.

Authors:  Taylor L Fuss; Leo L Cheng
Journal:  Top Magn Reson Imaging       Date:  2016-10

2.  First application of 7-T ultra-high field diffusion tensor imaging to detect altered microstructure of thalamic-somatosensory anatomy in trigeminal neuralgia.

Authors:  John W Rutland; Kuang-Han Huang; Corey M Gill; Dillan F Villavisanis; Judy Alper; Gaurav Verma; Joshua B Bederson; Bradley N Delman; Raj K Shrivastava; Priti Balchandani
Journal:  J Neurosurg       Date:  2019-08-30       Impact factor: 5.115

3.  Altered structure and functional connection in patients with classical trigeminal neuralgia.

Authors:  Yuan-Hsiung Tsai; Rui Yuan; Dharni Patel; Subhashini Chandrasekaran; Hsu-Huei Weng; Jen-Tsung Yang; Ching-Po Lin; Bharat B Biswal
Journal:  Hum Brain Mapp       Date:  2017-11-06       Impact factor: 5.038

4.  3D magnetic resonance spectroscopic imaging reveals links between brain metabolites and multidimensional pain features in fibromyalgia.

Authors:  Jeungchan Lee; Ovidiu C Andronesi; Angel Torrado-Carvajal; Eva-Maria Ratai; Marco L Loggia; Akila Weerasekera; Michael P Berry; Dan-Mikael Ellingsen; Laura Isaro; Asimina Lazaridou; Myrella Paschali; Arvina Grahl; Ajay D Wasan; Robert R Edwards; Vitaly Napadow
Journal:  Eur J Pain       Date:  2021-06-22       Impact factor: 3.651

Review 5.  Electroencephalographic Patterns in Chronic Pain: A Systematic Review of the Literature.

Authors:  Eulália Silva dos Santos Pinheiro; Fernanda Costa de Queirós; Pedro Montoya; Cleber Luz Santos; Marion Alves do Nascimento; Clara Hikari Ito; Manuela Silva; David Barros Nunes Santos; Silvia Benevides; José Garcia Vivas Miranda; Katia Nunes Sá; Abrahão Fontes Baptista
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

6.  Spatial-temporal signature of resting-state BOLD signals in classic trigeminal neuralgia.

Authors:  Yanping Wang; Congying Xu; Liping Zhai; Xudong Lu; Xiaoqiang Wu; Yahui Yi; Ziyun Liu; Qiaobing Guan; Xiaoling Zhang
Journal:  J Pain Res       Date:  2017-12-05       Impact factor: 3.133

7.  Alterations of Dynamic Regional Homogeneity in Trigeminal Neuralgia: A Resting-State fMRI Study.

Authors:  Jianhao Yan; Meng Li; Shishun Fu; Guomin Li; Tianyue Wang; Yi Yin; Guihua Jiang; Jingzhi Lin; Wuming Li; Jin Fang; Junzhang Tian
Journal:  Front Neurol       Date:  2019-10-09       Impact factor: 4.003

8.  Altered regional homogeneity of spontaneous brain activity in idiopathic trigeminal neuralgia.

Authors:  Yanping Wang; Xiaoling Zhang; Qiaobing Guan; Lihong Wan; Yahui Yi; Chun-Feng Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-13       Impact factor: 2.570

9.  Acupuncture therapy in treating migraine: results of a magnetic resonance spectroscopy imaging study.

Authors:  Tao Gu; Lei Lin; Yun Jiang; Juan Chen; Ryan Cn D'Arcy; Min Chen; Xiaowei Song
Journal:  J Pain Res       Date:  2018-04-27       Impact factor: 3.133

10.  The thalamus in trigeminal neuralgia: structural and metabolic abnormalities, and influence on surgical response.

Authors:  Hayden Danyluk; Jennifer Andrews; Rohit Kesarwani; Peter Seres; Robert Broad; B Matt Wheatley; Tejas Sankar
Journal:  BMC Neurol       Date:  2021-07-24       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.